In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.

The brain and vagus nerve play a key role in exacerbating tissue damage after a heart attack, but there are ways to block it.

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...

Maintaining a stable heartbeat is critical for survival. Your heart must constantly adapt its output to meet changing demands ...

Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

Scientists have identified a key reason why more than half of people with chronic kidney disease eventually die from heart-related conditions. New evidence shows that damaged kidneys release a ...

SGMC Health is expanding its advanced cardiac imaging capabilities with the introduction of Positron Emission Tomography (PET) cardiac stress testing, offering patients faster, more accurate ...

Ifetroban significantly improved LVEF in DMD patients, showing a 5.4% improvement compared with propensity-matched natural history controls, with high-dose treatment yielding the most benefit. The ...